Literature DB >> 25523612

The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways.

Tatyana Isayeva1, Jie Xu1, Camille Ragin2, Qian Dai1, Tiffiny Cooper1, William Carroll1, Dan Dayan3, Marilena Vered3, Bruce Wenig4, Eben Rosenthal1, William Grizzle1, Joshua Anderson1, Christopher D Willey1, Eddy S Yang1, Margaret Brandwein-Gensler1.   

Abstract

A large body of evidence shows that p16(INK4a) overexpression predicts improved survival and increased radiosensitivity in HPV-mediated oropharyngeal squamous cell carcinomas.(OPSCC). Here we demonstrate that the presence of transcriptionally active HPV16 in oral cavity squamous cell carcinomas does not correlate with p16(INK4a) overexpression, enhanced local tumor immunity, or improved outcome. It is interesting that HPV-mediated oropharyngeal squamous cell carcinomas can be categorized as having a 'nonaggressive' invasion phenotype, whereas aggressive invasion phenotypes are more common in HPV-negative squamous cell carcinomas. We have developed primary cancer cell lines from resections with known pattern of invasion as determined by our validated risk model. Given that cell lines derived from HPV-mediated oropharyngeal squamous cell carcinomas are less invasive than their HPV-negative counterparts, we tested the hypothesis that viral oncoproteins E6, E7, and p16(INK4a) can affect tumor invasion. Here we demonstrate that p16(INK4a) overexpression in two cancer cell lines (UAB-3 and UAB-4), derived from oral cavity squamous cell carcinomas with the most aggressive invasive phenotype (worst pattern of invasion type 5 (WPOI-5)), dramatically decreases tumor invasiveness by altering expression of extracellular matrix remodeling genes. Pathway analysis integrating changes in RNA expression and kinase activities reveals different potential p16(INK4a)-sensitive pathways. Overexpressing p16(INK4a) in UAB-3 increases EGFR activity and increases MMP1 and MMP3 expression, possibly through STAT3 activation. Overexpressing p16(INK4a) in UAB-4 decreases PDGFR gene expression and reduces MMP1 and MMP3, possibly through STAT3 inactivation. Alternatively, ZAP70/Syk might increase MUC1 phosphorylation, leading to the observed decreased MMP1 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25523612     DOI: 10.1038/modpathol.2014.149

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  68 in total

1.  miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.

Authors:  Jonathon D Roybal; Yi Zang; Young-Ho Ahn; Yanan Yang; Don L Gibbons; Brandi N Baird; Cristina Alvarez; Nishan Thilaganathan; Diane D Liu; Pierre Saintigny; John V Heymach; Chad J Creighton; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2010-11-29       Impact factor: 5.852

2.  Role of human papilloma virus in oral tongue squamous cell carcinoma.

Authors:  Kalavathy Jayapal Elango; Amritha Suresh; Elango Murugaian Erode; Lakshmi Subhadradevi; Hiran Kattilaparambil Ravindran; Subramania Kulathu Iyer; Sundaram Karimassery Rama Iyer; Moni Abraham Kuriakose
Journal:  Asian Pac J Cancer Prev       Date:  2011

Review 3.  The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments.

Authors:  Agnieszka K Witkiewicz; Karen E Knudsen; Adam P Dicker; Erik S Knudsen
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

4.  Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma.

Authors:  Yufeng Li; Shuting Bai; William Carroll; Dan Dayan; Joseph C Dort; Keith Heller; George Jour; Harold Lau; Carla Penner; Michael Prystowsky; Eben Rosenthal; Nicolas F Schlecht; Richard V Smith; Mark Urken; Marilena Vered; Beverly Wang; Bruce Wenig; Abdissa Negassa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-12-19

5.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

6.  Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes.

Authors:  Li-Ang Lee; Chung-Guei Huang; Kuo-Chien Tsao; Chun-Ta Liao; Chung-Jan Kang; Kei-Ping Chang; Shiang-Fu Huang; I-How Chen; Tuan-Jen Fang; Hsueh-Yu Li; Shu-Li Yang; Li-Yu Lee; Chuen Hsueh; Tse-Ching Chen; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Shu-Hang Ng; Yu-Liang Chang; Chyong-Huey Lai; Shin-Ru Shih; Tzu-Chen Yen
Journal:  J Clin Virol       Date:  2013-05-10       Impact factor: 3.168

7.  p16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma.

Authors:  Lisa D Duncan; Marcus Winkler; Eric R Carlson; R Eric Heidel; Eugene Kang; David Webb
Journal:  J Oral Maxillofac Surg       Date:  2013-05-01       Impact factor: 1.895

8.  Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.

Authors:  Elaine M Smith; Justine M Ritchie; Kurt F Summersgill; Jens P Klussmann; John H Lee; Donghong Wang; Thomas H Haugen; Lubomir P Turek
Journal:  Int J Cancer       Date:  2004-02-20       Impact factor: 7.396

9.  p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.

Authors:  Esther M O'Regan; Mary E Toner; Stephen P Finn; Chun Yang Fan; Martina Ring; Bjorn Hagmar; Conrad Timon; Paul Smyth; Susanne Cahill; Richard Flavin; Orla M Sheils; John J O'Leary
Journal:  Hum Pathol       Date:  2008-03       Impact factor: 3.466

10.  11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.

Authors:  C C R Ragin; E Taioli; J L Weissfeld; J S White; K M Rossie; F Modugno; S M Gollin
Journal:  Br J Cancer       Date:  2006-09-26       Impact factor: 7.640

View more
  12 in total

1.  Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.

Authors:  C Cleary; J E Leeman; D S Higginson; N Katabi; E Sherman; L Morris; S McBride; N Lee; N Riaz
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-04-01       Impact factor: 4.126

2.  Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma.

Authors:  Mitra Mehrad; William D Dupont; W Dale Plummer; James S Lewis
Journal:  Head Neck Pathol       Date:  2017-12-12

3.  STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.

Authors:  L L Bu; G T Yu; L Wu; L Mao; W W Deng; J F Liu; A B Kulkarni; W F Zhang; L Zhang; Z J Sun
Journal:  J Dent Res       Date:  2017-06-12       Impact factor: 6.116

4.  Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients.

Authors:  Camille Ragin; Jeffrey C Liu; Gieira Jones; Olubunmi Shoyele; Bukola Sowunmi; Rachel Kennett; Harry J M Groen; Denise Gibbs; Elizabeth Blackman; Michael Esan; Margaret S Brandwein; Karthik Devarajan; Francesco Bussu; Rebecca Chernock; Chih-Yen Chien; Marc A Cohen; El-Mofty Samir; Suzuki Mikio; Gypsyamber D'Souza; Pauline Funchain; Charis Eng; Susanne M Gollin; Angela Hong; Yuh-S Jung; Maximilian Krüger; James Lewis; Patrizia Morbini; Santo Landolfo; Massimo Rittà; Jos Straetmans; Krisztina Szarka; Ruth Tachezy; Francis P Worden; Deborah Nelson; Samuel Gathere; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2016-12-26       Impact factor: 4.944

Review 5.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

6.  The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization.

Authors:  Timothy D Rohrbach; Nishi Shah; William P Jackson; Erin V Feeney; Samantha Scanlon; Robert Gish; Ryan Khodadadi; Stephen O Hyde; Patricia H Hicks; Joshua C Anderson; John S Jarboe; Christopher D Willey
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

7.  MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.

Authors:  Timothy D Rohrbach; Robert B Jones; Patricia H Hicks; Alice N Weaver; Tiffiny S Cooper; Nicholas J Eustace; Eddy S Yang; John S Jarboe; Joshua C Anderson; Christopher D Willey
Journal:  Oncol Lett       Date:  2016-12-29       Impact factor: 2.967

8.  Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.

Authors:  Gaurav Verma; Kanchan Vishnoi; Abhishek Tyagi; Mohit Jadli; Tejveer Singh; Ankit Goel; Ankita Sharma; Kiran Agarwal; Subhash Chandra Prasad; Durgatosh Pandey; Shashi Sharma; Ravi Mehrotra; Sukh Mahendra Singh; Alok Chandra Bharti
Journal:  Cancer Med       Date:  2017-02-03       Impact factor: 4.452

9.  Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data.

Authors:  Alex M Dussaq; Timothy Kennell; Nicholas J Eustace; Joshua C Anderson; Jonas S Almeida; Christopher D Willey
Journal:  PLoS One       Date:  2018-08-21       Impact factor: 3.240

10.  Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas.

Authors:  Valerie Dahm; Andrea Haitel; Alexandra Kaider; Isabella Stanisz; Andrea Beer; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.